Cost ‐effectiveness of liposomal amphotericin B in hospitalized patients with mucocutaneous leishmaniasis

ConclusionsIn the treatment of mucocutaneous leishmaniasis L‐AmB is a cost‐effective alternative to SbV and AmB‐D owing to its higher effectiveness, safety, and shorter course.This article is protected by copyright. All rights reserved.

Source: Tropical Medicine and International Health - October 27, 2017 Category: Tropical Medicine Authors: S óstenes Mistro, Bárbara Gomes, Lorena Rosa, Ligia Miranda, Marianne Camargo, Roberto Badaró Tags: Original Article Source Type: research